Clinical Trial Record

Return to Clinical Trials

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test


2019-01-01


2025-01-31


2030-01-31


1000

Study Overview

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

postoperative outcomes were evaluated by using inBody test

postoperative outcomes were evaluated by using inBody test

  • Cancer
  • BEHAVIORAL: inbody
  • Point study

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2022-02-01  

N/A  

2022-02-16  

2022-02-16  

N/A  

2022-02-25  

2022-02-25  

N/A  

2022-02  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
Primary Outcome MeasuresMeasure DescriptionTime Frame
long-term outcomesoverall survival rate5year
Secondary Outcome MeasuresMeasure DescriptionTime Frame
short-term outcomespostoperative complicationsup to 24 weeks

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • surgically treated patients

  • Exclusion Criteria:

  • a body weight loss of >10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Kimura J, Sui K, Tabuchi M, Sakamoto S, Murokawa T, Iwata J, Morita S, Iiyama T, Okabayashi T. Preoperative percent body fat in bioelectrical impedance analysis predicts pancreatic fistula after pancreaticoduodenectomy. Langenbecks Arch Surg. 2023 Jun 28;408(1):248. doi: 10.1007/s00423-023-02998-y.